|
2013-06-10 |
NeuroEPO in healthy volunteers. |
CIMAB |
Registered |
|
2013-06-14 |
Pneumococcal conjugate vaccination among Warao children |
SAIB |
Registered outdated |
|
2013-06-19 |
EGF-based vaccine with VChTV Schedule in hormone-refractory prostate tumors |
CIM |
Registered |
|
2013-06-19 |
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate |
FINLAY |
Registered |
|
2013-06-20 |
EGF vaccine- Advanced Lung tumors |
CIM |
Registered |
|
2013-06-20 |
CONTROLLED, DOUBLE-BLIND, RANDOMIZED, MULTICENTER, FASE IIIb TRIAL DESIGNED TO EVALUATE THE EFFICACY AND TOLERABILITY OF THE FIXED COMBINATION OF THIOCOLCHICOSIDE PLUS DICLOFENAC POTASSIUM IN ACUTE PAINFUL MUSCLE CONTRACTURE |
GUTIS |
Registered |
|
2013-06-21 |
SURFACEN ARDS. Pediatrics. Phase III |
CENSA |
Registered |
|
21/05/2021 |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
CIM |
Registered |
|
21/05/2021 |
Nimotuzumab in COVID-19 |
CIM |
Registered |
|
21/12/2020 |
Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study |
BIOCEN |
Registered |
|
22/01/2021 |
Curmeric- Safety-Community-Quarantine-COVID-19 |
CEADEN |
Registered |
|
22/01/2021 |
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19 |
CEADEN |
Registered |
|
22/01/2021 |
Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19 |
CEADEN |
Registered |
|
22/04/2014 |
Totally Laparoscopic Hysterectomy with Single-Port Access. Validation of a new technique in Cuba. |
CNCMA |
Registered |
|
22/04/2016 |
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II |
CIM |
Registered |
|
22/05/2015 |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
CIM |
Registered |
|
22/05/2015 |
Safety and pharmacokinetics of CIGB-552 |
CIGB |
Registered |
|
22/05/2020 |
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2 |
FINLAY |
Registered |
|
22/05/2020 |
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study |
FINLAY |
Registered |
|
22/05/2021 |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
CIM |
Registered |
